From research innovation to GMP excellence: How the Croda acquisition elevates your scientific journey

The pursuit of breakthrough scientific discoveries—from next-generation vaccines to advanced drug delivery systems—depends on more than just a great idea. It takes high-purity materials, technical expertise, and a trusted partner that evolves with you at every stage of development.

With Croda’s acquisition of Avanti Research, scientists now gain access to an unparalleled continuum of support, designed to take projects from early-stage innovation through GMP manufacturing—without the usual friction.

Here’s how this powerful partnership helps researchers go further, faster:

1. A seamless transition from bench to bedside

Avanti Research has been a cornerstone in lipid-based research for decades, offering highly specialized reagents for early-stage discovery. Now, with the global reach and GMP capabilities of Croda Pharma, that support doesn’t stop at the research phase.

We help you navigate the full development pipeline—from discovery and preclinical studies to clinical trials and commercial-scale production—so your innovations can reach patients more efficiently and confidently.

2. Expertise you can trust at every stage

Croda’s global scale and GMP-grade manufacturing facilities complement Avanti Research’s 50+ years of pioneering lipid innovation. Whether you're working on mRNA delivery, nanoparticle formulation, or vaccine adjuvants, our combined scientific and regulatory expertise ensures you're never alone in solving the complex challenges of product development.

Together, we provide more than just materials—we offer strategic support that helps you accelerate timelines and meet regulatory milestones with confidence.

3. Tailored solutions for your unique science

No two research programs are the same. That's why we specialize in custom solutions that adapt to your needs. Whether you're developing a targeted drug delivery platform, scaling up a lipid nanoparticle formulation, or formulating an innovative vaccine, our teams work hand-in-hand to design and deliver solutions that are fit for purpose and future-ready.

4. Quality and sustainability, without compromise

As part of Croda, Avanti Research maintains its renowned commitment to purity and consistency while embracing sustainable innovation. Our portfolio includes non-shark-derived squalene and other eco-conscious lipid excipients that align with your values without sacrificing performance.

We are proud to support environmentally responsible science, helping you build solutions that are as sustainable as they are effective.

5. Simplified supply, stronger support

Managing multiple vendors and disconnected workflows slows down progress. By integrating research-use-only (RUO) materials, clinical-grade excipients, and GMP-manufactured components under one trusted partner, we eliminate bottlenecks and streamline your path to commercialization.

From formulation troubleshooting to full-scale production, you’ll benefit from a cohesive, collaborative experience—so you can focus on what matters most: your science.

Your innovation, our commitment

At Avanti Research™, powered by Croda, we understand the urgency and complexity of transforming research into real-world impact. That's why we're more than a supplier—we’re a strategic partner dedicated to your success.

We bring together cutting-edge lipid technology, decades of formulation expertise, and end-to-end development capabilities to help you move from concept to clinic with clarity and confidence.